Our publications
Copaxone – publication of the decision
Following our IP Alert of 22 November 2024, the editable decision of 31 October 2024 (only the English text is authentic) is now available under reference AT.40588 : https://competition-cases.ec.europa.eu/cases/AT.40588 +
Data protection – June-December 2024
This newsletter presents a selection of legal news from June to December 2024 in the field of personal data protection. +
Patent protection for methods for treatment in Europe and the US
For European patents, methods for treatment by surgery or therapy are explicitly excluded from patentability by the legislation (Article 53 EPC), although the case law of the European Patent Office +
Revision of the USPTO patent fee schedule
On November 20, 2024, the U.S. Patent and Trademark Office (USPTO) announced a revised Patent fee schedule that will take effect on January 19, 2025. +
Effective withdrawal of an opt-out when national proceedings are pending
Court of Appeal Decision of the UPC of 11-12 2024 AIM SPORT DEVELOPMENT AG vs SUPPONOR +
New referral to the EPO Enlarged Board of Appeal – G 2/24
The Technical Board of Appeal of the EPO has referred a question to the Enlarged Board of Appeal to further clarify the status of a third party intervening during appeal +
The legal framework for organising e-sport events
The law defines e-sport as “a video game competition [that] pits two or more players or teams of players against each other for a score or victory”[1]. +
Quick recap: European patent practice regarding the patentability of surgical methods
The case law of the European Patent Office (EPO) concerning the patentability of surgical methods has undergone a significant evolution following decision G1/07 of the EPO’s Enlarged Board of Appeal +
New developments regarding CNIPA-EPO Pilot Programme
Starting from December 1, 2024, the search fees for designating the EPO as International Search Authority for applications participating in the CNIPA-EPO Pilot Programme may be paid in Chinese Yuan +
Copaxone: EU Commission fines Teva over misuse of the patent system and disparagement
Copaxone – EU Commission fines Teva €462.6 million over misuse of the patent system and disparagement. +
Russia: new patent legislation
Regulation No. 1278 published on 27 September 2024 makes a number of changes to Russian law. +
Change of practice in access to patent literature documents
Notice from the European Patent Office dated 2 July 2024 concerning a change of practice in access to patent literature documents cited in search and examination proceedings. +
Continuation of examination and opposition proceedings in view of referral G 1/24
Notice from the European Patent Office dated 1 July 2024 concerning the continuation of examination and opposition proceedings in view of referral G 1/24. +
Lavoix: Your trusted partner for litigation before the Unified Patent Court
Since the establishment of the Unified Patent Court (UPC) one year ago, Lavoix, a European group specialized in intellectual property, has asserted itself as a leader in managing patent litigation. +
Milan: the IP place to be!
On June 27, 2024, the Unified Patent Court (UPC) opened a new section of the Central Division in Milan, following the decision of the Administrative Committee of 26 June 2023 +
Romania will accede to the UPC agreement on September 1st 2024
Romania has deposited its instrument of ratification on May 31, 2024 and will accede to the UPC agreement on September 1st, 2024. Thus, starting from that date, the UPC agreement +
Legislative changes in India
On March 15, 2024, the Indian Ministry of Commerce and Industry published amendments in the Official Gazette, modifying certain patent rules from 2003. +
Data protection – News for 2023-2024
This newsletter presents a selection of legal news in the field of personal data protection for the year 2023-2024. +
What is the benefit of registering a patronymic brand for an athlete?
Many athletes benefit from brand protection that allows them to effectively combat opportunism and significantly increase their visibility. +
Cumulative Protection under the UPC Framework
Cumulative Protection: European Patent and National Patent vs Unitary Patent and National Patent +
Overview of the EPO Strategic Plan 2028
The EPO recently published its new strategic plan for the coming years up to 2028. +
European Patent Office (EPO) has published a quality dashboard
The dashboard presents key performance indicators (KPIs) in quality and aims to enhance transparency by providing quarterly updates on quality and user satisfaction +
Wine labelling: creativity from constraint(s)
…or how to make the most of the latest mandatory statements to clarify the image of your wine and ensure its protection. +
Grandfather clause for European patent attorneys
A European Patent Attorney may represent a party before the UPC provided he has the appropriate qualifications. These qualifications are defined by the “Rules on the European Patent Litigation Certificate +
Stay of proceedings in case of parallel proceedings before the UPC and the EPO
In an order dated 8 January 2024, the Paris Central Division interpreted for the first time article 33 (10) of the Agreement concerning the stay of proceedings in the event +